CVX
44
-2
RHI
57
3
MA
57
2
PM
64
2
NRG
52
3
MS
76
2
AKAM
50
7
CAH
53
6
DOW
34
4
NWS
69
7
HD
55
8
DVN
18
2
MRO
40
-15
DE
56
10
LH
45
3
MDLZ
36
2
ZTS
49
2
VTR
54
5
COST
63
5
STZ
57
2
CVX
44
-2
RHI
57
3
MA
57
2
PM
64
2
NRG
52
3
MS
76
2
AKAM
50
7
CAH
53
6
DOW
34
4
NWS
69
7
HD
55
8
DVN
18
2
MRO
40
-15
DE
56
10
LH
45
3
MDLZ
36
2
ZTS
49
2
VTR
54
5
COST
63
5
STZ
57
2
Financhill
Back

Apellis Pharmaceuticals Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48

APLS
Apellis Pharmaceuticals

Last Price:
30.76
Seasonality Move:
16.11%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Apellis Pharmaceuticals Price Quote

$30.76
-0.01 (10.85%)
(Updated: November 23, 2024 at 3:25 AM ET)

Apellis Pharmaceuticals Key Stats

Sell
48
Apellis Pharmaceuticals (APLS) is a Sell
Day range:
$27.71 - $30.99
52-week range:
$24.34 - $73.80
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.30
P/B ratio:
16.14%
Volume:
2.7M
Avg. volume:
3.6M
1-year change:
-35.4%
Market cap:
$3.8B
Revenue:
$396.6M
EPS:
$-2.03

How Much Does Apellis Pharmaceuticals Make?

Is Apellis Pharmaceuticals Growing As A Company?

Apellis Pharmaceuticals Stock Price Performance

What Is Apellis Pharmaceuticals 52-Week High & Low?

Apellis Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Apellis Pharmaceuticals?

Is Apellis Pharmaceuticals Cash Flow Positive?

  • What Is APLS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$205.1M
  • What Is Apellis Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $149.3M
  • What Is Apellis Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$379K

Apellis Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    APLS return on invested capital is -52.47%
  • What Is Apellis Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -29.46%
  • What Is APLS Return On Equity?
    ROE is a measure of profitability and is -104.65%

Apellis Pharmaceuticals Earnings Date & Stock Price

Apellis Pharmaceuticals Competitors

Apellis Pharmaceuticals Dividend Yield

Apellis Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -71.42%
Revenue: 78.29% -1.5%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 7
Sell Recommendations: 0
Price Target: 45.75
Upside from Last Price: 48.68%

Major Shareholders

  • How many APLS shares are owned by institutional investors?
    191.6M APLS shares are owned by institutional investors
  • How many APLS shares are owned by insiders?
    3.8M APLS shares are owned by insiders